Advertisement
BAX vs MDT
Which Stock Would AI Choose? Baxter International (BAX) vs. Medtronic (MDT) Stock Comparison
Key Takeaways
- Baxter International (BAX) and Medtronic (MDT) operate in the medical devices and healthcare technology sector, with Medtronic (MDT) maintaining a larger market capitalization and broader product portfolio.
- Recent market activity shows Baxter International (BAX) posting stronger year-to-date returns compared to Medtronic (MDT), though both have experienced volatility amid sector-wide pressures.
- Medtronic (MDT) reported its strongest annual revenue growth in a decade during its fiscal 2026 results, while Baxter International (BAX) delivered mixed first-quarter outcomes with an organic sales decline.
- Upcoming earnings for Baxter International (BAX) in late July carry expectations of year-over-year earnings per share (EPS) contraction, contrasting with Medtronic (MDT)’s recent positive momentum.
- Sector exposure and risk factors differ, with Baxter International (BAX) facing greater recent share price pressure over the trailing twelve months relative to Medtronic (MDT).
- Market sentiment reflects cautious optimism for both, influenced by macroeconomic factors, earnings visibility, and healthcare utilization trends.
Introduction
Investors and traders often compare Baxter International (BAX) and Medtronic (MDT) due to their positions in the medical devices industry, where innovation, regulatory developments, and global demand for healthcare products drive performance. This analysis examines their business models, recent price behavior, and relative positioning in the current market environment. The comparison appeals to those evaluating healthcare sector exposure, seeking contrasts in growth trajectories, stability, and catalysts amid evolving economic conditions.
Baxter International (BAX) Overview and Recent Performance
Baxter International (BAX) develops and manufactures medical products focused on renal care, hospital products, and surgical solutions. In recent market activity, the stock has shown resilience with year-to-date gains near 17%, outperforming the broader S&P 500 benchmark in that timeframe, though trailing twelve-month returns remain negative. Recent weeks highlighted volatility, including additions to indexes like the Russell 2500 and preparations for second-quarter earnings expected on July 30. First-quarter results beat estimates on a reported basis but reflected an organic sales decline, with analysts projecting a notable earnings per share (EPS) contraction year-over-year. Sentiment has been shaped by these mixed fundamentals alongside external factors such as tariffs and manufacturing costs.
Medtronic (MDT) Overview and Recent Performance
Medtronic (MDT) is a global leader in medical technology, offering devices and therapies across cardiovascular, diabetes, and neurological segments. Recent market activity reflects steady performance, with year-to-date returns around 13% and modest one-year gains, though below the S&P 500. The company delivered its highest annual revenue growth in ten years for fiscal 2026, supported by strong fourth-quarter results and organic expansion. Recent weeks included a dividend increase marking the 49th consecutive year of growth. Sentiment benefits from operational execution and portfolio strength, tempered by broader sector multiples and analyst price target adjustments.
Trending AI Robots
Tickeron’s Trending AI Robots page highlights a curated selection of AI trading bots from hundreds available on the platform. These bots trade thousands of different tickers using varied styles, strategies, timeframes, and performance metrics tailored to prevailing market conditions. Only the most suitable bots for current environments earn placement in this section, with available options often demonstrating ranges of win rates, profit factors, and drawdown statistics across diverse portfolios. The platform enables users to explore bots suited to specific risk profiles and objectives. Explore the full selection at Trending AI Robots for additional insights.
Head-to-Head Comparison
Baxter International (BAX) maintains a more focused portfolio in renal and hospital products, while Medtronic (MDT) benefits from diversified exposure across high-growth areas like cardiovascular and diabetes care. Growth drivers favor Medtronic (MDT) following its record fiscal year revenue increase, contrasted with Baxter International (BAX)’s recent organic challenges. Recent momentum shows Baxter International (BAX) with stronger year-to-date price appreciation amid index inclusions, whereas Medtronic (MDT) exhibits greater stability in earnings delivery. Risk factors include Baxter International (BAX)’s higher trailing twelve-month share price decline and upcoming earnings scrutiny, versus Medtronic (MDT)’s exposure to regulatory and competitive pressures in medical devices. Sector sentiment remains neutral for both, with trade-offs centering on scale versus specialized recovery potential.
Tickeron AI Verdict
Based on observable factors such as recent revenue growth consistency and earnings visibility, Tickeron’s AI would likely assign a modest probabilistic preference to Medtronic (MDT) in the current environment. Its demonstrated top-line expansion and dividend stability provide a clearer positioning relative to Baxter International (BAX)’s mixed quarterly results and near-term earnings expectations. This assessment reflects relative trend alignment without implying definitive outcomes.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and MDT is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 1 FA rating(s) are green whileMDT’s FA Score has 1 green FA rating(s).
- BAX’s FA Score: 1 green, 4 red.
- MDT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 3 TA indicator(s) are bullish while MDT’s TA Score has 7 bullish TA indicator(s).
- BAX’s TA Score: 3 bullish, 4 bearish.
- MDT’s TA Score: 7 bullish, 3 bearish.
Price Growth
BAX (@Pharmaceuticals: Other) experienced а -0.13% price change this week, while MDT (@Medical/Nursing Services) price change was +0.61% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.44%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.61%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.62%. For the same industry, the average monthly price growth was -1.16%, and the average quarterly price growth was -16.57%.
Reported Earning Dates
BAX is expected to report earnings on Jul 30, 2026.
MDT is expected to report earnings on Aug 25, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.44% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+7.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BAX | MDT | BAX / MDT | |
| Capitalization | 11.7B | 107B | 11% |
| EBITDA | 750M | 9.81B | 8% |
| Gain YTD | 18.225 | -11.501 | -158% |
| P/E Ratio | 87.85 | 22.40 | 392% |
| Revenue | 11.3B | 36.4B | 31% |
| Total Cash | 2.02B | 9.22B | 22% |
| Total Debt | 9.69B | 28B | 35% |
BAX | MDT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 72 | |
PRICE GROWTH RATING 1..100 | 45 | 57 | |
P/E GROWTH RATING 1..100 | 33 | 60 | |
SEASONALITY SCORE 1..100 | 85 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MDT's Valuation (3) in the Medical Specialties industry is significantly better than the same rating for BAX (94). This means that MDT’s stock grew significantly faster than BAX’s over the last 12 months.
MDT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BAX (100). This means that MDT’s stock grew similarly to BAX’s over the last 12 months.
MDT's SMR Rating (72) in the Medical Specialties industry is in the same range as BAX (96). This means that MDT’s stock grew similarly to BAX’s over the last 12 months.
BAX's Price Growth Rating (45) in the Medical Specialties industry is in the same range as MDT (57). This means that BAX’s stock grew similarly to MDT’s over the last 12 months.
BAX's P/E Growth Rating (33) in the Medical Specialties industry is in the same range as MDT (60). This means that BAX’s stock grew similarly to MDT’s over the last 12 months.
| BAX | MDT | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 60% | 7 days ago 57% |
| Stochastic ODDS (%) | 4 days ago 65% | 4 days ago 44% |
| Momentum ODDS (%) | N/A | 4 days ago 60% |
| MACD ODDS (%) | 4 days ago 54% | 7 days ago 48% |
| TrendWeek ODDS (%) | 4 days ago 66% | 4 days ago 52% |
| TrendMonth ODDS (%) | 4 days ago 62% | 4 days ago 45% |
| Advances ODDS (%) | 4 days ago 56% | 4 days ago 52% |
| Declines ODDS (%) | 14 days ago 66% | 14 days ago 57% |
| BollingerBands ODDS (%) | 4 days ago 54% | 4 days ago 43% |
| Aroon ODDS (%) | 4 days ago 61% | 4 days ago 32% |
Advertisement
BAX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BAX has been loosely correlated with LUNG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then LUNG could also see price increases.
| Ticker / NAME | Correlation To BAX | 1D Price Change % | ||
|---|---|---|---|---|
| BAX | 100% | -0.22% | ||
| LUNG - BAX | 53% Loosely correlated | -5.19% | ||
| STE - BAX | 51% Loosely correlated | +0.49% | ||
| SYK - BAX | 51% Loosely correlated | +0.51% | ||
| XRAY - BAX | 47% Loosely correlated | +4.24% | ||
| A - BAX | 47% Loosely correlated | -0.19% | ||
More | ||||
MDT and
Correlation & Price change
A.I.dvisor indicates that over the last year, MDT has been loosely correlated with SYK. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MDT jumps, then SYK could also see price increases.